Invivyd, Inc. (IVVD)
NASDAQ: IVVD · Real-Time Price · USD
1.890
+0.090 (5.00%)
At close: Mar 9, 2026, 4:00 PM EDT
1.880
-0.010 (-0.53%)
After-hours: Mar 9, 2026, 7:41 PM EDT
Invivyd Market Cap
Invivyd has a market cap or net worth of $534.10 million as of March 9, 2026. Its market cap has increased by 269.02% in one year.
Market Cap
534.10M
Enterprise Value
309.91M
1-Year Change
269.02%
Ranking
Category
Stock Price
$1.89
Market Cap Chart
Since August 6, 2021, Invivyd's market cap has decreased from $2.27B to $534.10M, a decrease of -76.43%. That is a compound annual growth rate of -27.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 507.58M | -25.85% |
| Dec 31, 2025 | 684.49M | 1,191.45% |
| Dec 31, 2024 | 53.00M | -87.78% |
| Dec 29, 2023 | 433.85M | 165.40% |
| Dec 30, 2022 | 163.47M | -79.76% |
| Dec 31, 2021 | 807.69M | -64.36% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neumora Therapeutics | 547.20M |
| Ocugen | 544.31M |
| Lexeo Therapeutics | 543.03M |
| Lyell Immunopharma | 541.72M |
| REGENXBIO | 535.74M |
| Immix Biopharma | 533.81M |
| Fulcrum Therapeutics | 528.81M |
| Century Therapeutics | 528.16M |